Slide Staining Reagents for the Anatomic Pathology Laboratory, Walter Reed National Military Medical Center
ID: HT001424R0024Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/8e2d48ffc70d46a98c8dd2042d6039bc/view
Timeline
    Description

    The Department of Defense seeks non-proprietary information about slide staining reagents for the Anatomic Pathology Laboratory at the Walter Reed National Military Medical Center in Bethesda, Maryland.

    The primary objective is to acquire Agilent chemical slide reagents, which are proprietary to Agilent Technologies, for use with the existing Agilent Artisan Link Pro platforms. These reagents are essential for providing patient care support in the laboratory.

    The scope of work involves supplying the reagents necessary for the efficient operation of the medical center's pathology lab. Respondents should be able to provide the specific reagents required by Agilent Artisan Link Pro systems and ensure a consistent supply.

    Interested parties should meet the following criteria to be considered eligible:

    • Hold a valid NAICS code of 334516: Analytical Laboratory Instrument Manufacturing.
    • Possess the requisite certifications and qualifications to supply the specific reagents outlined by the medical center.
    • Have a DUNS number and be registered on SAM.gov.

    Funding for this requirement is anticipated to come from the Defense Health Agency's budget. The contract type will be determined based on the outcomes of this sources-sought notice. Respondents should not include price information in their submissions.

    If you wish to respond, please email Kendall Spann at kendall.j.spann.ctr@health.mil with your non-proprietary information. The government will not accept responsibility for any proprietary or sensitive commercial information included in the responses.

    The evaluation of submissions will be based on the relevance and quality of the proposed slide staining reagents and the ability to meet the laboratory's requirements. Price will not be a determining factor in this selection process.

    For further clarification or questions, you may contact Kendall Spann via email at kendall.j.spann.ctr@health.mil.

    Point(s) of Contact
    Kendall Spann
    kendall.j.spann.ctr@health.mil
    Files
    No associated files provided.
    Similar Opportunities
    Reagent Dispenser
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured reagent dispensers through a Sources Sought notice. The procurement aims to identify U.S.-made products that meet stringent specifications, including features such as custom plate addition, high precision peristaltic pumping, and a dispensing volume capacity ranging from 0.5 to 2500μl, among others. This initiative underscores the importance of domestic manufacturing in scientific and medical instrumentation, aligning with the Buy American Act and Executive Order 14005. Interested vendors must submit their capability statements by October 25, 2024, to Kelly Lowe at kelly.lowe@nih.gov, ensuring compliance with the outlined requirements and confidentiality stipulations.
    BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide leasing, consumables, and maintenance services for the BD FACSLyric™ 3L10C system, as part of a sources sought announcement. The procurement aims to ensure the continued operation of critical laboratory equipment used for immunology flow cytometry, which is essential for delivering over one million test results annually for patient care and research. This opportunity emphasizes the need for proprietary reagents and robust support from the manufacturer, highlighting the importance of consistent and reliable testing in a clinical research environment. Interested parties must submit their responses by 12:00 PM Eastern Standard Time on October 23, 2024, to the primary contact, Kimala Winfield, at kimala.winfield@nih.gov.
    Sources Sought Notice for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment, consumables, controls, and any necessary services to conduct Flow Cytometry Testing at BAMC
    Active
    Dept Of Defense
    The Department of Defense, specifically the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement to provide flow cytometry testing services at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of FDA-approved reagents, instruments, consumables, and necessary services, with a focus on maintaining a 98% operational uptime during business hours and ensuring compliance with regulatory standards such as CLIA and CAP. This opportunity is critical for supporting the Department of Pathology's laboratory services, which require advanced flow cytometry capabilities for various medical analyses. Interested parties must submit their responses by 4:00 PM CST on October 30, 2024, and can direct inquiries to Medina L. Woodson at medina.l.woodson.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.
    6640--FY25 11/01/2024 648 CPRR for Immunostainers New 5 year procurement
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for a five-year contract to provide "Cost Per Kit" services related to immunostainers at the Portland VA Medical Center. This procurement aims to enhance histology staining workflows by supplying modern immunostainers, a specimen tracking system, and high-quality reagents, while ensuring compliance with federal regulations and integration with existing IT systems. The total award amount for this contract is estimated at $41.5 million, with a focus on delivering high-quality healthcare solutions for veterans. Interested parties should contact Hector D Gonzalez at hector.gonzalez1@va.gov for further information regarding the solicitation.
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for reagents and consumables to STEMCELL Technologies Inc. for use with the RoboSep™-S Cell Separator Systems at the NIH Clinical Center in Bethesda, Maryland. The procurement includes specific items such as the EasySep HLA Chimerism WB Myeloid Positive Selection kit, the EasySep HLA Chimerism WB CD3 Positive Selection kit, and RoboSep Filter Tip Racks, which are critical for separating cell populations in allogeneic transplant patients to assess engraftment status. Interested vendors capable of providing equivalent products may submit a capability statement by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition falls under NAICS code 325414, and the total purchase order will not exceed the simplified acquisition threshold.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Sources Sought Notice for a Cost-Per-Test (CPT) Agreement to include reagents, instrument/equipment compatible with Hologic’s SARS CoV-2 & Flu A/B reagents at BAMC
    Active
    Dept Of Defense
    The Department of Defense, specifically the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement to provide reagents and equipment compatible with Hologic’s SARS CoV-2 & Flu A/B reagents for the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement aims to secure a fully automated molecular analyzer capable of processing a high volume of samples efficiently, along with necessary reagents and services to support nucleic acid amplification testing (NAAT) for various bacterial and fungal infections, including Bacterial Vaginosis and Chlamydia trachomatis. This initiative is part of broader public health strategies to enhance disease detection and management, particularly in women's health. Interested vendors should respond with their capabilities and relevant information by contacting Medina L. Woodson at medina.l.woodson.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil, with the base period of performance expected from June 1, 2025, to September 30, 2025.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    Laboratory Supplies and Wares - ECAT
    Active
    Dept Of Defense
    Presolicitation notice: Laboratory Supplies and Wares - ECAT The Department of Defense is seeking laboratory supplies and wares for various medical laboratories worldwide, including locations inside and outside the Continental United States (CONUS). These supplies are used by U.S. soldiers, sailors, airmen, and marines for research, diagnostics, and testing purposes. The solicitation aims to establish long-term contracts for the purchase of laboratory supplies through the DLA Electronic Catalog (ECAT). The estimated value of the contracts over a five-year period is $491,800,000.00, with a maximum value of $983,600,000.00. Interested parties can submit proposals at any time during the open periods of the solicitation. The Berry Amendment and the Trade Agreements Act apply to the laboratory items covered under this acquisition. For more information, contact Marie Crescenzo, the Contracting Officer, at marie.crescenzo@dla.mil. All responsible sources are encouraged to submit proposals.
    6640--Request For Information (RFI) For Automated Solid Phase Blood Bank Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 19, is seeking information from potential vendors regarding the rental of an automated solid-phase blood bank analyzer and the purchase of necessary testing reagents. The procurement aims to enhance blood bank testing capabilities, requiring the system to perform various tests, including ABO/Rh typing, antibody identification, and crossmatching, while also ensuring comprehensive quality control measures are in place. Interested parties must submit their capability statements, including business size status and contact information, to Contract Specialist Ernest Appiah by email by 9 AM Mountain Time on October 18, 2024. This is a sources sought notice only and does not constitute a request for proposal.